The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021
Sarah Mbaeyi(National Center for Immunization and Respiratory Diseases), Kathleen Dooling(Pfizer (United States)), Neela D. Goswami(Centers for Disease Control and Prevention), Kristine M Schmit(Team Industrial Services (United States)), Matthew F. Daley(Kaiser Permanente), Jefferson M. Jones(National Center for Immunization and Respiratory Diseases), Danielle Moulia(Centers for Disease Control and Prevention), Oliver Brooks, Heidi L. Moline(Centers for Disease Control and Prevention), Stephen C. Hadler(The Task Force for Global Health), Sujan Reddy(Centers for Disease Control and Prevention), Camille N. Kotton(Harvard University), Monica Godfrey, H. Keipp Talbot(Marshfield Clinic), Rebecca L. Morgan(Impact), Beth P. Bell(Centers for Disease Control and Prevention), Mary E. Chamberland, Doug Campos‐Outcalt, Grace Lee(Boston Children's Hospital), Jennifer P. Collins(Emory University), Sara E. Oliver(Centers for Disease Control and Prevention), Megan Wallace(Centers for Disease Control and Prevention)
Cited by 180
Related Papers
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update
|Infection Control and Hospital Epidemiology|2014|425
Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study
|Clinical Infectious Diseases|2020|407